| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215755 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 10 Pages |
Abstract
The pCR rate with decreased intensity of therapy with 60Â Gy of IMRT and weekly low-dose cisplatinum is very high in favorable-risk oropharyngeal squamous cell carcinoma, with evidence of decreased toxicity compared with standard therapies. ClinicalTrials.gov ID: NCT01530997.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bhishamjit S. MD, Robert J. MD, Joel MD, Bahjat PhD, Rebecca MSW, Shannon L. MA, Neil MD, MPH, Jared MD, Juneko MD, Adam MD, Trevor MD, William MD, Nathan MD, Mark MD, William MD,